Cabozantinib in Advanced Adrenocortical Carcinoma

Clinical trial NCT03612232 · UNKNOWN

Trial details

NCT number: NCT03612232
Sponsor: Wuerzburg University Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Adrenocortical Carcinoma

Start date: 2019-06-04
Primary completion: 2024-12-31
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.